Hypertrophic erythematous scar. Hypertrophic scar
Conditions
Interventions
Intervention 1: Control group: Treatment with PDL: Before the intervention, cleaning the lesion by using normal saline impregnated gas will be done. Then, 60 minutes before laser treatment, a local an
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients over 18 years Patients with a confirmed diagnosis of hypertrophic erythematous scars of at least 3 The size of the mentioned lesions should be at least 10 × 10 cm or have a length of at least 10 cm The patient is not pregnant or breast feeding The patient has not received any treatment for lesions such as laser, topical or injectable corticosteroids in the past two months The patient has no underlying diseases that lead to the healing process of the scar; Such as diabetes or weakened immune system The patient's cooperation in performing medical interventions and referring to all treatment sessions
Exclusion criteria
Exclusion criteria: Occurrence of pregnancy during treatment or follow-up period The occurrence of allergies or any side effects to one of the therapeutic interventions that prevent further treatment Diagnosis of malignancy or systemic disease during treatment or follow-up period The appearance of bacterial or viral skin diseases during treatment or follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of treatment. Timepoint: Three months after the first treatment session. Method of measurement: By using Vancouver scar scale (VSS) scoring method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety. Timepoint: One, two and three months after the first treatment session. Method of measurement: Questions about possible side effects of treatment.;Tolerability. Timepoint: One, two and three months after the first treatment session. Method of measurement: Question from the patient.;Satisfaction. Timepoint: One, two and three months after the first treatment session. Method of measurement: Based on patient scoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNajmossadat Atefi
Iran University of Medical Sciences
Outcome results
None listed